Percutaneous Interventional Radiology: The Lung

  • Kien Vuu
  • Antonio Gutierrez
  • Fereidoun Abtin
  • Christopher Lee
  • Robert Suh
Reference work entry

Abstract

Percutaneous ablation techniques have emerged as a viable treatment option for primary and secondary lung malignancies. Utilizing minimally invasive image-guided approaches, these techniques allow for the precise placement of ablation devices with the goal of total tumor necrosis and local control, offering in some instances curative potential. The different ablative technologies used in the thorax are based on application of thermal energies, chemical lysis, and alteration of cell permeability, the thermal energies most extensively studied thus far. These ablative techniques provide a valuable stand-alone alternative to conventional surgical resection or an adjunct to surgery, chemotherapy, or radiotherapy. The development of these and additional novel therapies has resulted in a multidisciplinary approach for the treatment of primary and secondary pulmonary malignancies with percutaneous ablative techniques proving to be a robust therapeutic option. To date, radiofrequency ablation (RFA) is the best developed and most widely used thermal ablation technique in the lung. Using radiofrequency ablation as a model for thermal ablation, this chapter will outline the principles of thermal ablation, the role of thermal ablation in the treatment of primary and secondary pulmonary malignancies, the procedural-related complications of thermal ablation within the lung, post-ablation follow-up and treatment results, as well as a brief discussion and comparison of the different ablative technologies.

Keywords

Permeability Microwave Ischemia Attenuation Argon 

References

  1. 1.
    American Cancer Society, Cancer Facts and Figures. 2010. www.cancer.org.
  2. 2.
    Jemal A, Taylor M, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin. 2005; Jan-Feb;55:10–30. Erratum in: CA Cancer J Clin. 2005 Jul-Aug;55:259.Google Scholar
  3. 3.
    Willis RA. Secondary tumours of the lung. In: Willa RA, editor. The spread of tumours in the human body. London: Butterworths; 1973. p. 167–74.Google Scholar
  4. 4.
    Figlin RA, Holmes EC, Turrisi AT, et al. Neoplasms of the lung, pleura, and mediastinum. In: Haskell CM, editor. Cancer treatment. 4th ed. Philadelphia: WB Saunders; 1995. p. 385–413.Google Scholar
  5. 5.
    Pass HI, Donington JS. Metastatic cancer of the lung. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven; 1997. p. 2536–51.Google Scholar
  6. 6.
    Zierhut D, Bettscheider C, Schubert K, et al. Radiation therapy of stage I and II non-small cell lung cancer. Lung Cancer. 2001;34:39–43.CrossRefGoogle Scholar
  7. 7.
    Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350:379–92.CrossRefPubMedGoogle Scholar
  8. 8.
    Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Mountain CF. A new international staging system for lung cancer. Chest. 1986;89(suppl):225S–33.CrossRefPubMedGoogle Scholar
  10. 10.
    Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346(2):92–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Ginsberg RJ, Port JL. Surgical therapy of stage I, and non-T3 NO stage II non-small lung cancer. In: Pass H, Mitchell JB, Johnson DH, editors. Lung cancer: principles and practice of oncology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 682–93.Google Scholar
  12. 12.
    Ihde DC, Pass HI, Glatstein E. Small cell lung cancer. In: DeVita Jr VT, Hellman S, Rosenber SA, editors. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 911–49.Google Scholar
  13. 13.
    Deslauriers J. Current surgical treatment of nonsmall cell lung cancer 2001. Eur Respir J. 2002;19(suppl):61S–70.CrossRefGoogle Scholar
  14. 14.
    Lung. In: American joint committee on cancer: AJCC cancer staging manual. 7th ed. New York: Springer; 2009. p 253–70.Google Scholar
  15. 15.
    Ginsberg RJ, Rubinstein LV, Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 nonsmall cell lung cancer. Ann Thorac Surg. 1995;60:615–23.CrossRefPubMedGoogle Scholar
  16. 16.
    McGarry RC, et al. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121:1155–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin. 1994;44:7–26.CrossRefPubMedGoogle Scholar
  18. 18.
    Morgan-Parkes JH. Metastases: mechanisms, pathways, and cascades. AJR Am J Roentgenol. 1995;164:1075–82.CrossRefPubMedGoogle Scholar
  19. 19.
    Chen PW, Pass HI. Indications for resection of pulmonary metastases. In: Baue AE, Stanford CT, editors. Glenn’s thoracic and cardiovascular surgery. 6th ed. Stanford: Appleton & Lange; 1996. p. 499–510.Google Scholar
  20. 20.
    Landreneau RJ, De Giacomo T, Mack MJ, et al. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. Eur J Cardiothorac Surg. 2000;18:671–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Goldberg SN, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228:335–54.CrossRefPubMedGoogle Scholar
  22. 22.
    Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities–part I. J Vasc Interv Radiol. 2001;12:1021–32.CrossRefGoogle Scholar
  23. 23.
    Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg. 1984;38:323–30.CrossRefPubMedGoogle Scholar
  24. 24.
    Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for foal malignancy: a unified approach to underlying principles, techniques and diagnostic imaging guidance. AJR Am J Roentgentol. 2000;174:323–31.CrossRefGoogle Scholar
  25. 25.
    Goldberg SN, Gazell GS, Compton CC, et al. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol. 1996;3:929–35.CrossRefPubMedGoogle Scholar
  26. 26.
    Rose SC, Thistlethwaite PA, Sewell PE, et al. Lung cancer and radiofrequency ablation. J Vasc Interv Radiol. 2006;17:927–51.CrossRefPubMedGoogle Scholar
  27. 27.
    Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25:s69–83.CrossRefPubMedGoogle Scholar
  28. 28.
    Kawamura M, Izumi Y, Tsukada N, Asakura K, Sugiura H, et al. Percutaneous cryoablation of small pulmonary tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiol Surg. 2006;131:1007–13.CrossRefGoogle Scholar
  29. 29.
    Wang H, Littrup P, Duan Y, et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289–98.CrossRefPubMedGoogle Scholar
  30. 30.
    Rosenberg C, et al. Laser ablation of metastatic lesions of the lung: long-term outcome. Am J Roentegenol. 2009;192:785–92.CrossRefGoogle Scholar
  31. 31.
    Vogl TJ, Mack MG, Nabil M. Laser induced thermotherapy in lung metastases. In: Vogl TJ, Helmberger TK, Mack MG, Reiser MF, editors. Percutaneous tumor ablation in medical radiology. 1st ed. Berlin/Heidelberg: Springer; 2008. p. 197–205.CrossRefGoogle Scholar
  32. 32.
    Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247(3):871–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Knappe V, Mol A. Laser therapy of the lung: biophysical background. Radiology. 2004;44:677–83.Google Scholar
  34. 34.
    Gofrit ON, Shapiro A, Pode D, et al. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology. 2004;63(3):466–71.CrossRefPubMedGoogle Scholar
  35. 35.
    Weigel C, Rosenberg C, Langner S, et al. Laser ablation of lung metastases: resultsaccording to diameter and location. Eur Radiol. 2006;16:1769–78.CrossRefPubMedGoogle Scholar
  36. 36.
    Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004;230:125–34.CrossRefPubMedGoogle Scholar
  37. 37.
    Abtin F, Wu C, Golshan A, Suh R. CT guided percutaneous cryoablation of thoracic tumors: technical feasibility, early efficacy and imaging of 27 treated tumors. Scientific session 8, #713, 2nd World congress of thoracic imaging and siagnosis in chest disease. Valencia May 30–June 2, 2009.Google Scholar
  38. 38.
    Steinke K, Haghighi KS, Wulf S, Morris DL. Effect of vessel diameter on the creation of ovine lung radiofrequency lesions in vivo: preliminary results. J Surg Res. 2005;124(1):85–91.CrossRefPubMedGoogle Scholar
  39. 39.
    Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol. 2004;15:463–70.CrossRefPubMedGoogle Scholar
  40. 40.
    Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small cell lung cancer. J Vasc Interv Radiol. 2006;17:1117–24.CrossRefPubMedGoogle Scholar
  41. 41.
    Oshima F, Yamakado K, Akeboshi M, et al. Lung radiofrequency ablation with and without bronchial occlusion: experimental study in porcine lungs. J Vasc Interv Radiol. 2004;15(12):1451–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Skonieczki BD, Wells C, Wasser EJ, Dupuy DE. Radiofrequency and microwave tumor ablation in patient with implanted cardiac devices: is it safe? Eur J Radiol. April 2010 (epub ahead of print).Google Scholar
  43. 43.
    Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation – preliminary results. Radiology. 2003;229:821–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Liao WY, Chen MZ, Chang YL, et al. US-guided transthoracic cutting biopsy for peripheral thoracic lesions less than 3 cm in diameter. Radiology. 2000;217:685–91.CrossRefPubMedGoogle Scholar
  45. 45.
    Wacker FK, Reither K, Ritz JP, et al. MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system. J Magn Reson Imaging. 2001;13:31–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Vogl TJ, Struab R, Eichler K, et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complication in 899 patients (2,520 lesions). Radiology. 2002;225:367–77.CrossRefPubMedGoogle Scholar
  47. 47.
    Silverman SG, Sun MR, Tuncali K, et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol. 2004;183:707–12.CrossRefPubMedGoogle Scholar
  48. 48.
    Shankar S, van Sonnenberg E, Silverman SG, et al. Brachial plexus injury from CT-guided RF ablation under general anesthesia. Cardiovasc Intervent Radiol. 2005;28:646–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Arata MA, Nisenbaum HL, Clark TW, et al. Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response? J Vasc Interv Radiol. 2001;12:455–8.CrossRefPubMedGoogle Scholar
  50. 50.
    Goldberg SN, Solbiati L, Halpern EF, et al. Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol. 2000;11:169–1075.CrossRefGoogle Scholar
  51. 51.
    Yamamoto A, Nakamura K, et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. Am J Roentgenol. 2005;185:1299–306.CrossRefGoogle Scholar
  52. 52.
    Aerospace Medical Association Medical Guidelines Task Force. Medical Guidelines for Airline Travel, 2nd edition. Aviat Space Environ Med. 2003;74(5):A1–19.Google Scholar
  53. 53.
    Simon CJ, Dupuy DE, Dipetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 Patients. Radiology. 2007;243:268–78.CrossRefPubMedGoogle Scholar
  54. 54.
    Hiraki T, Tajiri N, et al. Pneumothorax, pleural effusion, and chest tube placement after rf ablation of lung tumors: incidence and risk factors. Radiology. 2006;241:275–83.CrossRefPubMedGoogle Scholar
  55. 55.
    Sakurai J, Hiraki T, Mukai T. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol. 2007;18(1 Pt 1):141–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Yamakado A, Nakatsuka A, et al. Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol. 2005;28:530–2.CrossRefPubMedGoogle Scholar
  57. 57.
    Rose SC, Foothill M, Levin DL, Harrell JH. Cerebral microembolization during radiofrequency ablation of lung malignancies. J Vasc Interv Radiol. 2002;13:1051–4.CrossRefPubMedGoogle Scholar
  58. 58.
    Dupuy DE, Mayo-Smith WW, Abott GF, et al. Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics. 2002;22:259–69.CrossRefGoogle Scholar
  59. 59.
    Yamamoto A, Matsuoka T, Toyoshima M, et al. Assessment of cerebral microembolism during percutaneous radiofrequency ablation of lung tumors using diffusion-weighted Imaging. AJR Am J Roentgenol. 2004;183:1785–9.CrossRefPubMedGoogle Scholar
  60. 60.
    Ahrar K, Stafford RJ, Tinkey PT, et al. Evaluation of cerebral microemboli during radiofrequency ablation of lung tumors in a canine model with use of impedance-controlled devices. J Vasc Interv Radiol. 2007;18(7):929–35.CrossRefPubMedGoogle Scholar
  61. 61.
    Lencioni R. CC07c – Debate: lung cancer will always remain a surgery first disease versus radiofrequency ablation will shrink the role of surgery more than you know. Society of Interventional Radiology 32nd Annual Scientific Meeting, Seattle, March 3, 2007.Google Scholar
  62. 62.
    Okuma T, Okamura T, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med. 2006;20(2):115–21.CrossRefPubMedGoogle Scholar
  63. 63.
    Okuma T, Matsuoka T, et al. Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study. Br J Radiol. 2009;82:989–94.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastasis in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol. 2007;18:393–8.CrossRefPubMedGoogle Scholar
  65. 65.
    Yamakado K, Inoue Y, et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep. 2009;22:885–91.CrossRefPubMedGoogle Scholar
  66. 66.
    Suh R, Reckamp K, Zeidler M, Cameron R. Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology. 2005;19(11):1–10.Google Scholar
  67. 67.
    Chua TC, Sarkar A, Saxena A, Glenn D, Zhao J, Morris DL. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol. 2010;21(10):2017–22. Epub 2010 Mar 24.CrossRefPubMedGoogle Scholar
  68. 68.
    Sakurai J, Hiraki T, et al. Radiofrequency ablation of small lung metastases by a single application of a 2-cm expandable electrode: determination of favorable responders. J Vasc Interv Radiol. 2010;21:281–6.CrossRefGoogle Scholar
  69. 69.
    Inoue Y, Tanaka K, et al. Improved survival using multi-modality therapy in patients with lung metastases from colorectal cancer: a preliminary study. Oncol Rep. 2005;14:1571–6.PubMedGoogle Scholar
  70. 70.
    Chua TC, Thornbury K, et al. Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer. 2010;116(9):2106–14.PubMedGoogle Scholar
  71. 71.
    Davalos R, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33:223–31.CrossRefPubMedGoogle Scholar
  72. 72.
    Detterbeck FC, Botta DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136(1):260–71.CrossRefPubMedGoogle Scholar
  73. 73.
    Kawamura M, Izumi Y, Tsukada N, et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg. 2006;131:1007–13.CrossRefPubMedGoogle Scholar
  74. 74.
    Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg. 2010;211(1):68–72.CrossRefPubMedGoogle Scholar
  75. 75.
    Brace C, Hinshaw JL, Laesee PF, Sampson LA, Lee FT. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology. 2009;251:705–71.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Vogl TJ, Straub R, Lehnert T, et al. Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser-induced thermotherapy (LITT) and radiofrequency ablation (RFA) and a literature review. ROFO. 2004;176:1658–66.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Kien Vuu
    • 1
  • Antonio Gutierrez
    • 1
  • Fereidoun Abtin
    • 1
  • Christopher Lee
    • 2
  • Robert Suh
    • 1
  1. 1.Department of Radiological SciencesRonald Reagan UCLA Medical CenterLos AngelesUSA
  2. 2.Department of Radiology, Body DivisionKeck School of Medicine USC University HospitalLos AngelesUSA

Personalised recommendations